Skip to main content

Extrapyramidal symptoms and oestrogen

Buy Article:

$43.00 plus tax (Refund Policy)

Objective: The present study aimed to investigate neuroleptic side‐effect severity in women with psychosis, and to investigate their putative association with variations in sex steroids over the menstrual cycle. Based on the oestrogen hypothesis, which postulates a synergistic relationship between oestrogen and neuroleptics, it was hypothesized that oestrogen would exacerbate extrapyramidal symptoms.

Method: Twenty‐five psychotic women were assessed using the ESRS and blood hormone analysis. Testing was conducted twice, 2 weeks apart, in a randomized cross‐over design.

Results: Contrary to expectation the results indicated that high levels of oestrogen reduce hyperkinetic symptoms in women with psychosis, and this effect appears to be further potentiated when both estrogen and progesterone are high.

Conclusion: On the basis of these findings, and receptor studies in animals, it was concluded that oestrogen has different effects on dopamine dynamics in the mesolimbic and mesostriatal pathways.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: menstrual cycle; neuroleptics; oestrogen; schizophrenia; side‐effects; women

Document Type: Original Article

Affiliations: 1: Monash University Research Centre for Women's Mental Health, Dandenong Area Mental Health Service, Dandenong, Victoria 3175 and 2: Swinburne University of Technology, School of Biophysical Sciences and Electrical Engineering, Hawthorn, Victoria 3122, Australia.

Publication date: 2000-02-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more